[1] |
Hyuna S, Jacques F, Rebecca LS, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
[2] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
[3] |
李星, 曾晓勇. 中国前列腺癌流行病学研究进展[J]. 肿瘤防治研究, 2021, 48(1): 98-102.
|
[4] |
Eiber M, Kroenke M, Wurzer A, et al. 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy[J]. J Nucl Med, 2020, 61(5): 696-701.
|
[5] |
瞿旻, 高旭, 侯建国, 等. 前列腺癌患者根治术后生化复发危险因素的单中心研究[J]. 中华泌尿外科杂志, 2015, 36(8): 573-577.
|
[6] |
Fendler WP, Eiber M, Beheshti M, et al. 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0[J]. Eur J Nucl Med Mol Imaging, 2017, 44(6): 1014-1024.
|
[7] |
田蓉蓉, 赵铭, 周洁, 等. 18F-PSMA-1007 PET/CT对低PSA水平前列腺癌复发的检测价值[J]. 中华核医学与分子影像杂志, 2020, 40(10): 589-594.
|
[8] |
周文瑶, 张俊. 前列腺癌PSMA PET显像剂研究进展[J]. 中华核医学与分子影像杂志, 2020, 40(12): 755-760.
|
[9] |
Cheng G, Torigian DA, Zhuang H, et al. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?[J]. Eur J Nucl Med Mol Imaging, 2013, 40(5): 779-787.
|
[10] |
Schmuck S, Nordlohne S, von Klot C, et al. Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer[J]. Eur J Nucl Med Mol Imaging, 2017, 44(6): 960-968.
|
[11] |
Sahlmann C, Meller B, Bouter C, et al. Biphasic 68Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma[J]. Eur J Nucl Med Mol Imaging, 2016, 43(5): 898-905.
|
[12] |
Schmuck S, Mamach M, Wilke F, et al. Multiple Time-Point 68Ga-PSMA I&T PET/CT for Characterization of Primary Prostate Cancer[J]. Clin Nucl Med, 2017, 42(6): e286-e293.
|
[13] |
Beheshti M, Manafi-Farid R, Geinitz H, et al. Multiphasic 68Ga-PSMA PET/CT in the detection of early recurrence in prostate cancer patients with a psa level of less than 1 ng/ml: a prospective study of 135 patients[J]. J Nucl Med, 2020, 61(10): 1484-1490.
|
[14] |
Derlin T, Weiberg D, von Klot C, et al. (68)Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging[J]. Eur Radiol, 2016, 26(12): 4345-4353.
|
[15] |
Eiber M, Maurer T, Souvatzoglou M, et al. Evaluation of hybrid (6)(8)ga-psma ligand pet/ct in 248 patients with biochemical recurrence after radical prostatectomy[J]. J Nucl Med, 2015, 56(5): 668-674.
|